MiR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma

Laboratory Investigation

Volumn 95, Issue 12, 2015, Pages 1398-1408

  Jiang, Lie Hao ^a   Ge, Ming Hua ^a   Hou, Xiu Xiu ^a   Cao, Jun ^a   Hu, Si Si ^a   Lu, Xiao Xiao ^a   Han, Jing ^a   Wu, Yi Chen ^a   Liu, Xiang ^a   Zhu, Xin ^a   Hong, Lian Lian ^a   Li, Pei ^b   Ling, Zhi Qiang ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 21; PROGRAMMED CELL DEATH 4 PROTEIN; PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; MICRORNA; MIRN21 MICRORNA, HUMAN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN; STAT3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; MALE; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SALIVARY ADENOID CYSTIC CARCINOMA; SALIVARY GLAND CARCINOMA; WESTERN BLOTTING; CASE CONTROL STUDY; METABOLISM; MORTALITY; SALIVARY GLAND TUMOR; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS REGULATORY PROTEINS; CARCINOMA, ADENOID CYSTIC; CASE-CONTROL STUDIES; CELL LINE, TUMOR; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA-BINDING PROTEINS; SALIVARY GLAND NEOPLASMS; STAT3 TRANSCRIPTION FACTOR;

EID: 84948459810     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2015.105     Document Type: Article

References (49)

1. Moskaluk A. CA. Adenoid cystic carcinoma: clinical and molecular features. Head Neck Pathol 2013;7:17-22
2. Liu J, Shao C, Tan ML et al. Molecular biology of adenoid cystic carcinoma. Head Neck 2012;34:1665-1677
3. He JF, Ge MH, Zhu X et al. Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis. Cancer Sci 2008;99:1334-1340
4. Bradley PJ. Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 2004;12:127-132
5. Hu K, Gan YH, Li SL et al. Relationship of activated extracellular signalregulated kinase 1/2 with lung metastasis in salivary adenoid cystic carcinoma. Oncol Rep 2009;21:137-143
6. Zhang CY, Mao L, Li L et al. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma. Cancer 2007;110:87-95
7. Shi H, Wang J, Dong F et al. The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma. BMC Cancer 2009;9:456
8. Lagha A, Chraiet N, Ayadi M et al. Systemic therapy in the management of metastatic or advanced salivary gland cancers. Oral Oncol 2012;48:948-957
9. Ge MH, Chen C, Xu JJ et al. Critical regions and spreading of runtrelated transcription factor-3 C-phosphate-G (CpG) island methylation in human salivary gland adenoid cystic carcinoma. Hum Pathol 2011;42:1862-1872
10. Ge MH, Chen C, Xu JJ et al. Unfavorable clinical implications for hypermethylation of RUNX3 in patients with salivary gland adenoid cystic carcinoma. Oncol Rep 2011;26:349-357
11. Rutherford S, Hampton GM, Frierson HF et al. Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma. Lab Invest 2005;85:1076-1085
12. Stallmach I, Zenklusen P, Komminoth P et al. Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma. Virchows Arch 2002;440:77-84
13. Bernheim A, Toujani S, Saulnier P et al. High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma. Lab Invest 2008;88:464-473
14. Davis BN, Hata A. Micro RNA in Cancer-The involvement of aberrant Micro RNA biogenesis regulatory pathways. Genes Cancer 2010;1: 1100-1104
15. Nicolas FE, Lopez-Martinez AF. MicroRNAs in human diseases. Recent Pat DNA Gene Seq 2010;4:142-154
16. Liu L, Hu Y, Fu J et al. MicroRNA155 in the growth and invasion of salivary adenoid cystic carcinoma. J Oral Pathol Med 2013;42:140-147
17. Mitani Y, Roberts DB, Fatani H et al. Micro RNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One 2013;8:e66778
18. He Q, Zhou X, Li S et al. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway. Biochim Biophys Acta 2013;1830:5258-5266
19. Chen W, Zhao X, Dong Z et al. Identification of Micro RNA profiles in salivary adenoid cystic carcinoma cells during metastatic progression. Oncol Lett 2014;7:2029-2034
20. Sun L, Liu B, Lin Z et al. MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3. Mol Cancer 2015;14:96
21. Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009;37:918-925
22. Bera A, Das F, Ghosh-Choudhury N et al. microRNA-21-induced dissociation of PDCD4 from rictor Contributes to Akt-IKKβ-mTORC1 axis to regulate select renal Cancer cell invasion. Exp Cell Res 2014;328:99-117
23. Zhu S, Wu H, Wu F et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008;18:350-359
24. Turkson J, Jove R. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 2000;19:6613-6626
25. Bowman T, Garcia R, Turkson J et al. STATs in oncogenesis. Oncogene 2000;19:2474-2488
26. Wei W, Tweardy DJ, Zhang M et al. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer. Stem Cells 2014;32:2571-2582
27. Bishop JL, Thaper D, Zoubeidi A. The multifaceted roles of STAT3 signaling in the progression of prostate cancer. Cancers (Basel) 2014;6:829-859
28. Panni RZ, Sanford DE, Belt BA et al. Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Cancer Immunol Immunother 2014;63:513-528
29. Ge Y, Yang B, Xu X et al. Cryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells. Leuk Lymphoma 2014;25:1-9
30. Munoz J, Dhillon N, Janku F et al. STAT3 inhibitors: finding a home in lymphoma and leukemia. Oncologist 2014;19:536-544
31. Qi QR, Yang ZM. Regulation and function of signal transducer and activator of transcription 3. World J Biol Chem 2014;5:231-239
32. Xiong A, Yang Z, Shen Y et al. Transcription factor STAT3 as a novel molecular target for cancer prevention. Cancers (Basel) 2014;6: 926-927
33. Zhang HF, Lai R. STAT3 in cancer-friend or foe? Cancers (Basel) 2014;6: 1408-1440
34. Hu K, Li SL, Gan YH et al. Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC-83 through activation of ERK and Akt. Oral Oncol 2009;45:156-163
35. International Union Against Cancer (UICC). In: Sobin LH, Gospodarowicz M.K., Wittekind C.H. (eds). TNM Classification of Malignant Tumors, 7th edn. Wiley-Liss: New York, 2010
36. Chen C, Ridzon DA, Broomer AJ et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005;33:e179
37. Lao K, Xu NL, Yeung V et al. Multiplexing RT-PCR for the detection of multiple miRNA species in small samples. Biochem Biophys Res Commun 2006;343:85-89
38. Ling ZQ, Guo W, Lu XX et al. A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers. Ann Oncol 2014;25:1363-1372
39. Ling ZQ, Lv P, Lu XX et al. Circulating methylated XAF1 DNA indicates poor prognosis for gastric cancer. PLoS One 2013;8:e67195
40. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are Micro RNA targets. Cell 2005;120:15-20
41. Krek A, Grn D, Poy MN et al. Combinatorial Micro RNA target predictions. Nat Genet 2005;37:495-500
42. John B, Enright AJ, Aravin A et al. Human Micro RNA targets. PLoS Biol 2004;2:e363
43. Li P, Mao WM, Zheng ZG et al. Down-regulation of PTEN expression modulated by dysregulated miR-21 contributes to the progression of esophageal cancer. Dig Dis Sci 2013;58:3483-3493
44. Zhu W, Xu B. MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis. PLoS One 2014;9:e103373
45. Roldo C, Missiaglia E, Hagan JP et al. Micro RNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006;24:4677-4684
46. Qi C, Shao Y, Li N et al. Prognostic significance of PDCD4 expression in human salivary adenoid cystic carcinoma. Med Oncol 2013;30:491
47. Matsuhashi S, Hamajima H, Xia J et al. Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells. Cell Signal 2014;26:603-610
48. Hwang SK, Baker AR, Young MR et al. Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65. Carcinogenesis 2014;35:1469-1480
49. Yang CH, Yue J, Pfeffer SR et al. Micro RNA miR-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem 2011;286: 39172-39178